HE - Hepatic Encephalopathy
PHASE 2 TREATMENT TRIAL
OHE/HE RNHE2041
Title: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)
Condition & Intervention: OHE: Rifaximin and lactulose (oral)
PI: Biggins, Landis
Site: UWMC, HMC